Victory Capital Management Inc Mirati Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$41.99 - $62.38 $16,796 - $24,952	400 Added 5.66%	7,466 $438,000
Q3 2023 Nov 06, 2023	BUY	$27.8 - $45.35 $35,139 - $57,322	1,264 Added 21.79%	7,066 $307,000
Q2 2023 Jul 27, 2023	SELL	$36.13 - $49.49 $4,841 - $6,631	-134 Reduced 2.26%	5,802 $209,000
Q1 2023 May 02, 2023	BUY	$36.54 - $54.26 $2,448 - $3,635	67 Added 1.14%	5,936 $220,000
Q4 2022 Feb 10, 2023	BUY	$41.27 - $98.62 $2,187 - $5,226	53 Added 0.91%	5,869 $265,000

Q4 2022 Feb 09, 2023	SELL	$41.27 - $98.62 $2,352 - $5,621	-57 Reduced 0.97%	5,816 $263,000
Q3 2022 Nov 02, 2022	BUY	$59.5 - $86.7 $349,443 - $509,189	5,873 New	5,873 $410,000
Q2 2022 Aug 01, 2022	SELL	$39.16 - $88.71 $4.24 Million - $9.59 Million	-108,150 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$75.82 - $150.97 $1.36 Million - $2.7 Million	17,910 Added 19.85%	108,150 $8.89 Million
Q4 2021 Feb 07, 2022	BUY	$132.01 - $190.29 $11.9 Million - $17.2 Million	90,240 New	90,240 $13.2 Million
Q2 2021 Aug 03, 2021	SELL	$144.0 - $179.73 $13.4 Million - $16.8 Million	-93,330 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$158.92 - $221.61 $47.2 Million - $65.8 Million	-296,812 Reduced 76.08%	93,330 $16 Million
Q4 2020 Feb 01, 2021	BUY	$162.05 - $240.27 $1.16 Million - $1.71 Million	7,131 Added 1.86%	390,142 $85.7 Million
Q3 2020 Nov 09, 2020	BUY	$113.26 - $167.27 $2.21 Million - $3.27 Million	19,551 Added 5.38%	383,011 $63.6 Million
Q2 2020 Aug 07, 2020	SELL	$72.01 - $120.39 $3.83 Million - $6.4 Million	-53,181 Reduced 12.76%	363,460 $41.5 Million
Q1 2020 May 04, 2020	SELL	$69.78 - $116.21 $517,139 - $861,232	-7,411 Reduced 1.75%	416,641 $32 Million
Q4 2019 Feb 06, 2020	SELL	$70.76 - $128.86 $253,957 - $462,478	-3,589 Reduced 0.84%	424,052 $54.6 Million
Q4 2019 Feb 04, 2020	BUY	$70.76 - $128.86 $5.4 Million - $9.84 Million	76,357 Added 21.74%	427,641 $37.1 Million
Q3 2019 Nov 12, 2019	BUY	$77.91 - $109.6 $6.35 Million - $8.93 Million	81,494 Added 30.21%	351,284 $27.4 Million
Q2 2019 Aug 15, 2019	BUY	$59.49 - $104.71 $16 Million - $28.2 Million	269,790 New	269,790 $27.8 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account